fbpx

Hvem er vi

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Christian Elling

Managing Partner
Paul Little

Paul Little

Operating Partner
Jette Brandsen Bundgaard

Jette Brandsen Bundgaard

PA / Office Manager

Engebret Lønnum

Student Assistant

Lundbeckfonden Emerge

Nyheder

IO Biotech Announces Late-Breaking Oral Presentation of Phase 2 Clinical Melanoma Data Including Complete Response (CR) Rate of 45 Percent
18. september 2020
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
14. juli 2020
AFYX Therapeutics Achieves Primary Endpoint in Phase 2b Trial of Rivelin-CLO in Patients with Oral Lichen Planus
22. april 2020